TIBER CREEK GROUP for JAZZ PHARMACEUTICALS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Medical/Disease Research/Clinical Labs MED
Issues related to cannabis research; S. 253 Cannabidiol and Marihuana Research Expansion Act; issues related to the FDA; issues related to Cannabis research at Health and Human Services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Budget/Appropriations BUD
Appropriations issues related to House Ag/FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products; Consolidated Appropriations Act, 2023 (PL 117-328).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.